Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds
Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence
Age Doesn’t Affect Survival After Bone Marrow Transplant
Lenalidomide Found Effective For Lymphoma In Phase II Trial
Intensive Chemo Equivalent To Transplant For MCL
Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant
Arzerra Promising For Heavily Pre-Treated CLL Patients
Dismissed Leukemia Drug Helps CLL, Clinical Trials Find
PDX Shows 27% Response In T-Cell Lymphoma In Study
Second-Generation CML Drugs Show Promise For Frontline
Gleevec To Prevent Recurrence Of Gastrointestinal Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Leading a Comprehensive Cancer Center—one job or two?
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- “This is our time, and the time is now”—Chapman tells us about Jefferson’s final push for Comprehensive designation
- Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week - Gynecology’s deadly surprise:
Cancers are frequently missed prior to routine procedures